FA
PJP icon

FDx Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History

FDx Advisors’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-4,044
Closed -$238K – 1231
2017
Q1 		$238K Sell
4,044
-5,169
-56% -$302K 0.01% 1048
2016
Q4 		$516K Buy
+9,213
New +$531K 0.01% 754

Other funds holding PJP

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
AI
Atria Investments Charlotte, North Carolina $9.98B AUM 26.5% 1-Year Est. Return

FDx Advisors's PJP Position: Q2 2017 in Review

FDx Advisors sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2017, closing a stake of 4,044 shares — an estimated $238K sold.

FDx Advisors first reported a position in PJP in Q4 2016 and held it in 2 quarters. The position peaked at $516K in Q4 2016. 99 funds tracked by Wall St. Rank hold PJP as of Q2 2017.

  • FDx Advisors reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2017 after selling out during the quarter.
  • FDx Advisors sold 4,044 Invesco Pharmaceuticals ETF shares in Q2 2017, an estimated $238K.
  • FDx Advisors first reported a position in Invesco Pharmaceuticals ETF in Q4 2016 and held it in 2 quarters.
  • FDx Advisors's Invesco Pharmaceuticals ETF position peaked at $516K in Q4 2016.
  • 99 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2017.

Based on FDx Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.